Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration

Andrea Frustaci1, Romina Verardo, Marina Caldarulo

  • 1Heart and Great Vessels Attilio Reale Department, La Sapienza University, Viale del Policlinico 155, Rome, Italy. biocard@inmi.it

European Heart Journal
|February 21, 2007
PubMed

Insights

Myocarditis, an inflammation of the heart muscle often caused by viruses, frequently leads to acute clinical deterioration in patients with hypertrophic cardiomyopathy (HCM). Identifying myocarditis in HCM patients can improve prognosis and treatment strategies.

Area of Science:

  • Cardiology
  • Pathology
  • Genetics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease.
  • Acute clinical deterioration in HCM patients can be severe and life-threatening.
  • The role of myocarditis in HCM exacerbations is not well understood.

Purpose of the Study:

  • To investigate the prevalence and impact of myocarditis in patients with hypertrophic cardiomyopathy.
  • To determine if myocarditis is a significant factor in acute electrical instability and clinical decline in HCM.

Main Methods:

  • 119 HCM patients (42 with acute deterioration, 77 stable) underwent cardiac catheterization and endomyocardial biopsy.
  • Biopsies were analyzed for histology, immunohistochemistry, and viral genomes.
  • Gene analysis of sarcomeric proteins was performed; controls had mitral stenosis.

Main Results:

  • Histological findings consistent with HCM were present in all patients.
  • Active myocarditis (CD45RO+ lymphocytes and myocyte necrosis) was found in 28 of 42 unstable HCM patients, but none of the stable patients.
  • Viral genomes were detected in 14 of the 28 myocarditis patients, but not in stable HCM patients or controls.

Conclusions:

  • Viral myocarditis is a common cause of acute clinical deterioration in hypertrophic cardiomyopathy.
  • Recognizing myocarditis in HCM patients is crucial for potentially improving disease prognosis and guiding treatment decisions.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
304
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
252
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
164
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
125
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
286
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
196